A comparative study measuring effectiveness of tofacitinib ointment and betamethasone valerate ointment to cure alopecia areata.
Phase 3
- Conditions
- Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2024/07/070905
- Lead Sponsor
- Bankura Sammilani Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients giving consent
All clinically diagnosed cases of alopecia areata
Not taken treatment of alopecia areata for last 1 month prior to enrolment
Exclusion Criteria
Pregnant and Lactating women
Patient taking immunosuppressive therapy.
Alopecia areata only of eyelash
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in hair lossTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method Adverse Effect Tolerability Quality of lifeTimepoint: 6 months